Sofinnova Investments’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
2024
Q2
$20.3M Sell
2024
Q1
$33.7M Sell
2023
Q4
$33.5M Buy
2023
Q3
$11.7M Buy
2023
Q2
$6.71M Sell
2023
Q1
$15.1M Buy
2022
Q3
Sell
2022
Q2
$1.3M Buy
2022
Q1
Sell
2021
Q4
$10.5M Buy
2021
Q3
$7.4M Buy
2021
Q2
$4.5M Buy